UNSPSC 51292019: Citalopram hydrobromide

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C20H21FN2O.BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I1E9D14F36, chemically known as 1,3-dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile but more generally known as citalopram hydrobromide, which bears US NIH Compound Identifier 2771.

UNSPSC 51292019 Citalopram hydrobromide is a Commodity code that nominally covers a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code does not reflect that scope. Seminole County, Florida posted an IFB in June 2026 (due July 26, 2023) for Naloxone and Safe Drug Deactivation Systems — products entirely unrelated to citalopram — indicating a mismatch between the code assignment and the actual procurement need. The county sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building. Vendors were required to submit unit costs for each line item, include all shipping and delivery costs in their proposals, and comply with drug-free workplace certification and E-Verify requirements. The contract included a two-year initial term with an option for a one-year renewal, and contractors had to maintain workers' compensation, commercial general liability, and professional liability insurance. FEMA funding introduced additional compliance obligations, including adherence to the Clean Air Act and Federal Water Pollution Control Act.

The code shows minimal recent activity and does not reflect a reliable market signal for citalopram procurement at the state and local level. The single recent opportunity posted was from a Florida county health department but centered on overdose-response and drug-deactivation products rather than psychiatric pharmaceuticals. Without additional opportunities under this code that align with its nominal scope, business development professionals should verify whether state and local buyers actually procure citalopram through this code designation or whether demand, if present, routes through other pharmaceutical or mental-health service codes.